JP2023513735A5 - - Google Patents

Info

Publication number
JP2023513735A5
JP2023513735A5 JP2022548856A JP2022548856A JP2023513735A5 JP 2023513735 A5 JP2023513735 A5 JP 2023513735A5 JP 2022548856 A JP2022548856 A JP 2022548856A JP 2022548856 A JP2022548856 A JP 2022548856A JP 2023513735 A5 JP2023513735 A5 JP 2023513735A5
Authority
JP
Japan
Prior art keywords
cancer
ptx3
pentraxin
hyaluronan
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548856A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513735A (ja
JP7886270B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017773 external-priority patent/WO2021163419A1/en
Publication of JP2023513735A publication Critical patent/JP2023513735A/ja
Publication of JP2023513735A5 publication Critical patent/JP2023513735A5/ja
Application granted granted Critical
Publication of JP7886270B2 publication Critical patent/JP7886270B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548856A 2020-02-12 2021-02-12 がん細胞を死滅させるまたはがん細胞の成長を阻害する方法 Active JP7886270B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062975599P 2020-02-12 2020-02-12
US62/975,599 2020-02-12
PCT/US2021/017773 WO2021163419A1 (en) 2020-02-12 2021-02-12 Methods of killing or inhibiting the growth of cancer cells

Publications (3)

Publication Number Publication Date
JP2023513735A JP2023513735A (ja) 2023-04-03
JP2023513735A5 true JP2023513735A5 (cg-RX-API-DMAC7.html) 2024-02-21
JP7886270B2 JP7886270B2 (ja) 2026-07-07

Family

ID=77292678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548856A Active JP7886270B2 (ja) 2020-02-12 2021-02-12 がん細胞を死滅させるまたはがん細胞の成長を阻害する方法

Country Status (8)

Country Link
US (1) US20230083005A1 (cg-RX-API-DMAC7.html)
EP (1) EP4103592A4 (cg-RX-API-DMAC7.html)
JP (1) JP7886270B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220143689A (cg-RX-API-DMAC7.html)
CN (1) CN115397841A (cg-RX-API-DMAC7.html)
AU (1) AU2021219772A1 (cg-RX-API-DMAC7.html)
CA (1) CA3170323A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021163419A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2023211823A1 (en) 2022-04-25 2023-11-02 Biotissue Holdings Inc. Compositions and methods relating to pooled fetal support tissue

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010115A1 (de) 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrogranulaten
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US5037677A (en) 1984-08-23 1991-08-06 Gregory Halpern Method of interlaminar grafting of coatings
US5356433A (en) 1991-08-13 1994-10-18 Cordis Corporation Biocompatible metal surfaces
US5336518A (en) 1992-12-11 1994-08-09 Cordis Corporation Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents
IT1298487B1 (it) 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
WO2009111159A2 (en) 2008-03-03 2009-09-11 New York University Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
ES2846789T3 (es) 2012-07-11 2021-07-29 Tissuetech Inc Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
US10342831B2 (en) * 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
CN113260370A (zh) * 2018-11-07 2021-08-13 组织技术公司 细胞重编程的方法

Similar Documents

Publication Publication Date Title
Wang et al. Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go
Zhang et al. Advancements of radiotherapy for recurrent head and neck cancer in modern era
Grodsky et al. Radiation proctopathy
US20220280233A1 (en) Devices, methods, and compositions for thermal acceleration and drug delivery
Araujo et al. Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options
Martin II et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma
Rogers et al. Radiotherapy for melanoma: More than DNA damage
JP2022500435A5 (cg-RX-API-DMAC7.html)
Teh et al. Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data
CN109069624A (zh) 癌症的免疫治疗
Zhou et al. A comprehensive review of BET-targeting PROTACs for cancer therapy
CN104800858B (zh) Hsp90抑制肽偶联物及其在肿瘤治疗中的应用
EP2780024B1 (en) Tumor vaccination
Zhao et al. Synergistically Augmenting Cancer Immunotherapy by Physical Manipulation of Pyroptosis Induction: C. Zhao et al.
Zhou et al. New advances in treatment of skin malignant tumors with nanosecond pulsed electric field: A literature review
Tian et al. Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy
Metcalfe et al. The safety and efficacy of radiofrequency and electrolytic ablation created adjacent to large hepatic veins in a porcine model
WO2009067520A3 (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
Crijnen et al. Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer
Xu et al. Comprehensive treatment of intermediate and advanced primary hepatocellular carcinoma based on transcatheter arterial chemoembolization
CN107137407B (zh) 一种vegfr抑制剂在制备治疗胰腺癌的药物中的用途
Lauffer et al. Pancreatic cancer: feasibility and outcome after radiochemotherapy with high dose external radiotherapy for non-resected and R1 resected patients
Sbeit et al. Endoscopic ultrasound role in pancreatic adenocarcinoma treatment: A review focusing on technical success, safety and efficacy
RU2478407C1 (ru) Способ комбинированного лечения местно-распространенного рака желудка
Kanekal et al. Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment